ACA Insurers Expand Condition-Specific Benefits as Premium Pressure Builds for 2027
Open enrollment for the Affordable Care Act marketplaces begins Nov. 1, and two of the sector’s biggest individual-market players are using the moment to frame 2027 around narrower benefit design, broader county reach and a more explicit attempt to match coverage with chronic disease burden. Centene’s Ambetter Health and Oscar Health both outlined new marketplace products for the coming year while insurers absorb the effects of expiring enhanced premium tax credits and a separate wave of federal program integrity rules that have already pushed premiums higher.
A KFF analysis released in August projected a median premium increase of 15% for 2027. That follows a second consecutive year of double-digit increases, after a median proposed increase of 18% for 2025. Insurers entering this filing cycle have had to price not only medical trend, but also the loss of subsidy support and the operational changes embedded in federal rules now facing legal challenges. The result is a marketplace where affordability pressure and product differentiation are advancing at the same time.
Centene Pushes Ambetter Deeper Into Chronic Disease Management
Centene said its Ambetter Health marketplace brand will expand into 55 new counties for 2027, extending its footprint to about 3.5 million members across 27 states and 1,700 counties. The company is pairing that geographic expansion with condition-specific plans under the Ambetter Health Premier umbrella, a strategy that reflects how tightly the exchange market now tracks chronic disease prevalence and medication adherence.
One of the clearest examples is a new set of plans in North Carolina and Ohio aimed at patients with congestive heart failure. Enrollees in those products will have $0 copayments for certain heart failure medications and up to four $0 cardiologist visits annually. The plans also include $0 copayments for certain mental health medications and nicotine replacement therapy, along with coverage for cholesterol labs, electrocardiograms, cardiac education programs and nutritional counseling. In practical terms, the benefit structure is designed to reduce the friction points that often drive poor adherence in heart failure: medication cost, follow-up gaps and the low uptake of lifestyle counseling that can stabilize symptoms between acute episodes.
Heart failure care depends on sustained medication use and frequent reassessment of volume status, rhythm disturbance and lipid burden. Removing cost-sharing from those visits and tests is more than a consumer perk; it is a direct attempt to prevent avoidable decompensation in a condition where small disruptions in treatment can lead to hospitalization.
Centene is also widening its diabetes-focused products into Louisiana, Mississippi and Indiana. Those plans already operate in Florida, Tennessee, Texas, Alabama and Oklahoma. Members can access $0 preferred insulin, $0 copayments for certain medications used to manage diabetes, high blood pressure, high cholesterol and mental health conditions, plus no-cost diabetes supplies and routine A1C laboratory services. For patients with diabetes, the package targets the basic drivers of glycemic instability: insulin affordability, supplies, comorbidity treatment and laboratory monitoring. Even modest delays in medication fills or A1C testing can push patients toward preventable microvascular and macrovascular complications, so the value of these benefits lies in continuity rather than novelty.
The company is also broadening asthma and chronic obstructive pulmonary disease coverage. Those plans include $0 copays for preferred asthma or COPD medications, pulmonology visits, allergy tests and pulmonary rehabilitation services. Pulmonary rehab remains one of the most underused tools in chronic lung disease, despite its role in exercise tolerance, symptom control and self-management. Lowering the cost barrier may matter as much as the medication benefit itself.
In its traditional plans, Ambetter continues to offer around-the-clock virtual care, while some states include the My Health Pays rewards program for completing designated health challenges. Katherine Kirby, president of Ambetter Health, said the company is committed to coverage options that reflect the healthcare needs of the communities it serves, and pointed to member satisfaction and primary care engagement in the condition-specific offerings.
Oscar Health Adds Retirement Transition Coverage and More Bundled Benefits
Oscar Health is taking a different but equally segmented path. The company said it will offer plans in 713 counties across 21 states for 2027, a 24% increase in counties served. Its new offering, RetireEase, is designed for people moving from early retirement into Medicare eligibility and will be available in Arizona, Florida, Ohio, South Carolina and Texas.
RetireEase is built around continuity. Members can keep seeing trusted providers and will face set prices for preventive care, laboratory services, physical therapy, heart care and bone-and-joint care. The plan also includes no-cost generic drugs, along with supports for caregiving, transportation and the transition to Medicare. For people leaving employer-based coverage before Medicare begins, the handoff can be clinically fragile; gaps in specialist visits, medications or physical therapy can quickly disrupt care plans for cardiovascular disease, musculoskeletal conditions and routine preventive services.
Oscar is also expanding products aimed at specific life stages and practical needs. The HelloMeno plan, designed for women navigating menopause, will grow to 15 states. Members in those plans can access a $0 package of services that includes hormone therapy, bone-density scans, insomnia treatment and cancer screenings. The structure reflects a straightforward clinical logic: menopause affects sleep, bone health and symptom burden, and these issues often intersect with screening and long-term risk assessment rather than a single isolated diagnosis.
A separate co-branded offering, Hy-Vee Health with Oscar, will expand within Iowa and into Nebraska, Missouri and Kansas. That plan includes concierge care services and food discounts at Hy-Vee stores. Oscar also said it will add more than 250 new plans that bundle vision and dental services automatically, including $0 preventive dental visits and eye exams, plus discounts for vision care. Its Oscar Unlocks rewards program remains part of the product mix.
Mark Bertolini, Oscar Health’s CEO, framed the individual market as a place that has to serve entrepreneurs, part-time workers, gig workers and employees across company sizes. His comments emphasize convenience and technology, but the clinical signal is broader: insurers are increasingly packaging benefits around life stage, provider continuity and common chronic conditions rather than offering a one-size-fits-all exchange product.
Marketplace Design Is Moving Toward Narrower Risk, Not Broader Uniformity
The 2027 filings show how ACA competition is evolving under pressure. Insurers are not just widening county maps; they are building products around high-frequency conditions that drive utilization and cost. Heart failure, diabetes, asthma, COPD, menopause and the transition to Medicare all carry predictable patterns of medication use, follow-up visits and ancillary testing. By lowering or eliminating cost-sharing for the services most likely to prevent deterioration, carriers are trying to align member retention with clinical engagement.
The question for 2027 is not whether these designs are more tailored. They are. The real test is whether lower out-of-pocket costs for targeted services can offset a market environment shaped by higher premiums, subsidy uncertainty and rule changes that continue to alter how insurers price risk and how patients shop for coverage. For members, the next open enrollment cycle will show whether these product changes soften the impact of rising premiums or simply narrow the path to care inside a more expensive marketplace.